产品编号：D436532

产品规格：5mg

产品价格：面议

---

产品详情

标准品编号:	D436532
名称:	Diclofenamide-13C6
别名:	1,3-Disulfamoyl-4,5-dichlorobenzene-13C6; 1,3-Disulfamyl-4,5-dichlorobenzene-13C6; 3,4-Dichloro-5-sulfamylbenzenesulfonamide-13C6; 4,5-Dichloro-1,3-disulfamoylbenzene-13C6; 4,5-Dichloro-m-benzenedisulfonamide-13C6; Antidrasi-13C6; CB 8000-13C6; Daramide-13C6; Daranide-13C6; Dichlofenamide-13C6; Dichlorophenamide-13C6; Dichlorphenamide-13C6; Diclofenamid-13C6; Glaucol-13C6; Oratrol-13C6;
CAS号:	1391054-76-4
参考CAS号:	类似: 120-97-8
分子式:	¹³C₆H₆Cl₂N₂O₄S₂
外观:	Light Brown Solid
熔点:	>220°C (dec.)
分子量:	311.11
储存:	冰箱保存
溶解性:	Chloroform (Slightly), DMSO (Slightly)
种类:	Building Blocks; Isotopic Labeled Analogues; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
应用:	Labelled Diclofenamide, a potent carbonic anhydrase inhibitor. Diclofenamide may provide a therapeutic strategy in the inhibition of the human cytosolic isoforms I and II and transmembrane tumor-associated isoenzymes IX and XII. Diclofenamide has been shown to be is effective in the prevention of episodic weakness in both hypokalemic periodic paralysis (HypoPP) and potassium-sensitive periodic paralysis (PSPP).
参考文献	Brzozowski, Z. et al.: Eur. J. Med. Chem., 46, 3656 (2010); Tawil, R. et al.: Ann. Neurol., 47, 46 (2000); Casey, J. et al.: J. Med. Chem., 47, 2337 (2004);